Virus-Related Lymphoma — Trials

Virus-Related Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 36
Recruiting: 19
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 101–106 of 106 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00006473	Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma	completed	Phase 2	72	National Cancer Institute (NCI)NIH	1	Jan 23, 2013	clinicaltrials
NCT00005080	506U78 in Treating Patients With Lymphoma	completed	Phase 2	74	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials